apremilast,deucravacitinib
amgen,bms
['otezla']
in two phase 3 tests in adults, once-daily pill #sotyktu led to significantly more patients achieving skin clearance compared to treatment with twice-daily #otezla, a blockbuster pill that blocks a different enzyme, pde4. 
Business journalist based in #RTP, covering pharma and biotech (almost) everywhere. 71% free throw shooter. Genesis: Album 9, track 11.